Pleurisy Market Size, Share, Growth Forecast 2032

Pleurisy Market Overview

Pleurisy Market Size was valued at USD 1.73 Billion in 2023. The Pleurisy industry is projected to grow from USD 1.83 Billion in 2024 to USD 3.23 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.94% during the forecast period (2024 - 2032).

Pleurisy is the inflammation of the membrane known as pleura that surrounds the lungs inside the chest cavity. People suffering with pleurisy can experience chest pain while breathing. This disease is characterized by symptoms such as shortness of breath, cough, fever, and weight loss. Pneumonia, pulmonary embolism, autoimmune disorder, lung cancer, heart surgery, pancreatitis, chest trauma, and asbestosis are the diseases which cause pleurisy, thus, rising in population affected with these disease are the leading factor for the growth of global pleurisy market. According to a report published by the World Cancer Research Fund International, in 2015, about 58% of lung cancer cases occurred in the developing countries. In a similar report by Centers for Disease Control and Prevention (CDC), in 2017, lung cancer is the leading cause of cancer death and the second most common cancer among both men and women in the United States.

There are various causes responsible for this condition, such as rising aging population, unhealthy diet, low physical activities, etc. According to a research, smoking increases the possibility of lung cancer; more than 60% of the global population smokes, this has increased the risk of lung cancer and contributed to the growth of the market. Moreover, advancing technology in medical devices is adding fuel to the growth of the market. Furthermore, increasing government support for the developing countries also drives the market growth. However, availability of expensive treatment and poor reimbursement policies in the developing regions of the world are some of the factors, which may hamper the market growth during the forecast period.

Pleurisy Market Segment Insights

The pleurisy global market is segmented on the basis of diagnosis devices, treatment, and by end user. On the basis of the diagnosis devices, it is segmented into thoracentesis, video-assisted thoracic surgery, imaging devices, blood test, and others. Furthermore, imaging devices are segmented as computed tomography, magnetic resonance imaging, ultrasound, and others.

On the basis of the treatment, it is segmented into antibiotics, antifungals, blood thinners, nonsteroidal anti-inflammatory drugs, and others. On the basis of end user, it is segmented into hospital, clinics, diagnostics laboratories, and others.

Pleurisy Market Regional Analysis

The Americas dominate the global pleurisy market owing to the rising prevalence of disease such as autoimmune disorders, lung cancer, heart surgery, pancreatitis, chest trauma. Furthermore increasing government support for research & development and high healthcare spending have fuelled the growth of the market in this region. According to a report published by the Centers for Disease Control and Prevention (CDC), in 2014, around 215,951 people in the United States were diagnosed with lung cancer, including 113,326 men and 102,625 women. Also around 155,526 people in the United States died from lung cancer, including 84,859 men and 70,667 women.

Europe holds the second position in the global pleurisy market owing to the government support for research & development and availability of funds for research. Moreover, people of this region are more healthcare awareness. This is expected to continue to drive the European market over the forecasted period.

Asia Pacific is the fastest growing pleurisy market owing to the high presence of patient with chronic disease. Although rapidly developing healthcare technology, increasing demand for new treatment methods in countries like India and China is likely to emerge as the fastest growing market across the globe. Furthermore, increasing demand for quality devices in the healthcare provide the opportunity for the market players to fill the gap between demand and supply and maximize the profits.

On the other hand, in the Middle East and Africa, hold the least market due to low research and development activities and poor healthcare infrastructure.

Pleurisy Market Key Players

Some of the key players in this market are:

Scanlan International, Inc. (U.S.)

Sontec Instruments (U.S.)

Pilling Surgical Inc. (U.S.)

Integra LifeSciences Corporation (U.S.)

Olympus Corporation (Japan)

Delacroix-Chevalier (France)

Myra & Co. (India)

Wexler Surgical (Texas)

Research Methodology

Sources: Annual reports, Press release, White paper, and Company presentation

Intended Audience

Medical Devices Manufacturers

Government Research Laboratories

Research and Development (R&D) Companies

Government and Independent Regulatory Authorities

Market Research and Consulting Service Providers

Medical Research Laboratories

Report Attribute/Metric	Details
Market Size	3.23 Billion
CAGR	6.94%
Base Year	2023
Forecast Period	2024-2032
Historical Data	2020
Forecast Units	Value (USD Billion)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	Diagnosis devices, Treatment and End user
Geographies Covered	North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Vendors	Scanlan International, Inc. (U.S.), Sontec Instruments (U.S.), Pilling Surgical Inc. (U.S.), Integra LifeSciences Corporation (U.S.), Olympus Corporation (Japan), Delacroix-Chevalier (France), Myra & Co. (India), Wexler Surgical (Texas)
Key Market Opportunities	Quality Devices Manufacturer
Key Market Drivers	Rising aging population· Unhealthy diet· Low physical activities

Pleurisy Market Highlights:

Frequently Asked Questions (FAQ) :

What is pleurisy?

There is a membrane called pleura inside the chest cavity that surrounds the lungs. Any type of inflammation in it is known as pleurisy.

What would be pleurisy market CAGR during the forecast period (2022-2030)?

Pleurisy market CAGR during the forecast period would be 6.8% during the forecast period.

Name the players included in the pleurisy market report?

Pleurisy market players are Scanlan International, Inc. (U.S.), Integra LifeSciences Corporation (U.S.), Sontec Instruments (U.S.), Delacroix-Chevalier (France), Olympus Corporation (Japan), Wexler Surgical (Texas), Myra & Co. (India), Pilling Surgical Inc. (U.S.), and others.

Which region would dominate the pleurisy market?

The Americas would lead the global pleurisy market platform.

Which region would grow with the highest CAGR among all pleurisy market regions?

The Asia Pacific would garner the maximum CAGR among all pleurisy market regions.

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

FEATURES	LICENCE TYPE
FEATURES	Single User	Multiuser Licence	Enterprise User
Price	$ 4,950	$ 5,950	$ 7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout The Organization.
Free Customization
Direct access to the Analyst
Deliverable Format
Deliverable Format
Platform Access
Discount on Your Next Purchase	10%	15%	10%
Printable Versions

Pleurisy Market Research Report Information: By Diagnosis Devices (Thoracentesis, Video-Assisted Thoracic Surgery, Blood Test), By Treatment (Antibiotics, Antifungals, Blood Thinners), By End User (Hospital, Clinics, Diagnostics Laboratories) -Forecast till 2032